| 2017 | | Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes | 한승진 |
| 2023 | | Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study | 이관우 |
| 2012 | | Effects of Ethyl Acetate Extract of Poncirus trifoliata Fruit for Glucocorticoid-Induced Osteoporosis | 정윤석 |
| 2017 | | Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort | 이관우, 전기홍 |
| 2002 | | Effects of Nateglinide on the Control of Mealtime Glucose Excursions in Korean Patients with Type 2 Diabetes | 김대중, 김현만, 이관우, 정윤석 |
| 2004 | | Effects of Pamidronate Treatment on Osteogenesis Imperfecta | 김대중, 김현주, 이관우, 정윤석 |
| 2013 | | Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type2 diabetes. | 김혜진 |
| 2015 | | Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study. | 김대중, 김혜진, 신승수, 이관우, 한승진 |
| 2007 | | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 김대중, 이관우 |
| 2019 | | Effects of sarpogrelate on microvascular complications with type 2 diabetes | 김대중, 박인휘 |
| 2004 | | Effects of secreted frizzled-related protein 3 on osteoblasts in vitro. | 정윤석 |
| 2017 | | Effects of Single Vitamin D(3) Injection (200,000 Units) on Serum Fibroblast Growth Factor 23 and Sclerostin Levels in Subjects with Vitamin D Deficiency | 정윤석 |
| 2019 | | Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study | 김대중, 이기황, 정유리, 하경화 |
| 2006 | | Effects of stress management group psychotherapy on glycemic control in type 2 diabetes: Preliminary study | 김대중, 이관우 |
| 2017 | | Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study | 김대중, 김혜진, 이관우, 한승진 |
| 2022 | | Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial | 이관우 |
| 2024 | | Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study | 한승진 |
| 2023 | | Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension | 김혜진 |
| 1999 | | Efficacy and Safety of Glimepiride: A Novel Sulfonylurea Drug Compared with Gliclazide in the Treatment of Type 2 Diabetes Mellitus: an Open, Randomized Comparative Multi-Center Clinical Study | 이관우 |
| 2017 | | Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) | 이관우 |
| 2018 | | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial | 이관우 |
| 2024 | | Efficacy and Safety of Metformin and AtorvastatinCombination Therapy vs. Monotherapy with EitherDrug in Type 2 Diabetes Mellitus and DyslipidemiaPatients (ATOMIC): Double-Blinded RandomizedControlled Trial | 김대중 |
| 2014 | | Efficacy and safety of sustained-release recombinant human growth hormone in Korean adults with growth hormone deficiency. | 정윤석 |
| 2021 | | Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study | 김혜진, 이관우 |
| 2019 | | Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report | 김혜진, 이관우 |
| 2016 | | Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency | 정윤석, 최용준 |
| 2019 | | Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial | 이관우 |
| 2014 | | Efficacy and safety of weekly alendronate plus vitamin D(3) 5600 IU versus weekly alendronate alone in Korean osteoporotic women: 16-week randomized trial. | 정윤석 |
| 2020 | | Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial | 김혜진 |
| 2015 | | Efficacy of a Once-Monthly Pill Containing Ibandronate and Cholecalciferol on the Levels of 25-Hydroxyvitamin D and Bone Markers in Postmenopausal Women with Osteoporosis. | 정윤석 |
| 1999 | | Efficacy of questionnaire for the diagnosis of diabetic peripheral neuropathy in koreans | 김현만, 신영구, 이관우, 정윤석 |
| 2011 | | Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis. | 정윤석 |
| 2022 | | Electrocardiographic biomarker based on machine learning for detecting overt hyperthyroidism | 박래웅, 소문승, 전자영, 진우람 |
| 2012 | | Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes | 이관우 |
| 2013 | | Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. | 강엽, 이관우, 최성이 |
| 2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia | 김대중, 하경화 |
| 2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
| 2022 | | Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2000 | | Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera. | 강엽, 김현만 |
| 2015 | | Epidemiologic Characteristics of Dyslipidemia in Korea | 김대중, 하경화 |
| 2016 | | Epidemiology of Childhood Obesity in Korea | 김대중, 하경화 |
| 2008 | | Epidemiology of Hypoglycemia in Diabetes | 김혜진 |
| 2011 | | Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea | 김대중 |
| 2021 | | Erratum: Trends in cardiovascular complications and mortality among patients with diabetes in South Korea | 김대중, 하경화 |
| 1998 | | Evaluation of the Thyroid Disease | 김현만 |
| 2011 | | Exercise in the Elderly with Diabetes | 한승진 |
| 2017 | | Exposure to bisphenol A is directly associated with inflammation in healthy Korean adults | 김대중, 최용준, 하경화 |
| 2014 | | Extracellular visfatin activates gluconeogenesis in HepG2 cells through the classical PKA/CREB-dependent pathway. | 강엽, 김대중, 김혜진, 이관우, 최성이, 최용준, 한승진 |
| 2005 | | Extrapedicular approach of percutaneous vertebroplasty in the treatment of upper and mid-thoracic vertebral compression fracture. | 김찬, 정윤석, 한경림 |
